4//SEC Filing
Forbion Capital Fund II Cooperatief U.A. 4
Accession 0001104659-19-023695
CIK 0001760542other
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 4:15 PM ET
Size
17.5 KB
Accession
0001104659-19-023695
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2019-04-23$14.00/sh+53,571$749,994→ 2,494,173 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2019-04-23−687,673→ 0 total(indirect: See Footnote)→ Common Stock (687,673 underlying) - Conversion
Common Stock
2019-04-23+687,673→ 696,987 total(indirect: See Footnote) - Conversion
Common Stock
2019-04-23+1,146,118→ 1,843,105 total(indirect: See Footnote) - Conversion
Common Stock
2019-04-23+597,497→ 2,440,602 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2019-04-23−1,146,118→ 0 total(indirect: See Footnote)→ Common Stock (1,146,118 underlying) - Conversion
Series C Preferred Stock
2019-04-23−597,497→ 0 total(indirect: See Footnote)→ Common Stock (597,497 underlying)
Footnotes (2)
- [F1]The preferred stock automatically converted into the Issuer's common stock on a one-for-one basis at the closing of the Issuer's initial public offering held on April 23, 2019 without payment or further consideration and had no expiration date.
- [F2]Represents securities held by Forbion Capital Fund II Cooperatief U.A. ("Forbion Coop:"). Forbion II Management B.V. ("Forbion Management") is the director of Forbion Coop and may be deemed to have voting, investment and dispositive power with respect to the shares held by Forbion Coop. Forbion Management disclaims Section 16 beneficial ownership of the shares held by Forbion Coop, except to the extent, if any, of its pecuniary interest therein.
Documents
Issuer
HOOKIPA Pharma Inc.
CIK 0001760542
Entity typeother
Related Parties
1- filerCIK 0001767829
Filing Metadata
- Form type
- 4
- Filed
- Apr 24, 8:00 PM ET
- Accepted
- Apr 25, 4:15 PM ET
- Size
- 17.5 KB